The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo (Molecular Cancer Therapeutics (2002) (565-573))

Molecular Cancer Therapeutics

Volumn 2, Issue 2, 2003, Pages 208-

  Grand, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141974463     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Erratum

References (1)

1. Watts, G., Futscher, B. W., Issett, R., Gleason-Guzman, M., Kunkel, M. W.,and Salmon, S. E. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J. Pharmacol. Exp. Ther., 299: 434-441, 2001.